Bausch Health closes Wuhan Shibo acquisition

Mr. Thomas Appio reports BAUSCH HEALTH'S AESTHETICS BUSINESS, SOLTA MEDICAL, ACQUIRES LONGTIME DISTRIBUTION PARTNER, THE SHIBO GROUP, TO STRENGTHEN PRESENCE IN CHINA Bausch Health Companies Inc., along with its global aesthetic business, Solta Medical, has completed the acquisition of Wuhan Shibo Zhenmei Technology Co. Ltd., consisting of the Shibo group's aesthetics distribution business. The Shibo group has served as Solta Medical's trusted distribution partner over the past decade. Effective Dec. 1, 2025, Wuhan Shibo Zhenmei Technology became a wholly owned subsidiary of Solta Medical in China, assuming full responsibility for the distribution of Solta Medical's products, including Thermage FLX, as well as other aesthetic devices in the Chinese market. Thomas J. Appio, chief executive officer of Bausch Health, stated: "This acquisition expands Solta Medical's geographical reach and market scale in China. By leveraging an existing distribution network and local knowledge, Solta Medical can immediately gain access to the large customer base to drive future revenue and market share growth. Solta Medical delivers premium offerings, and we look forward to building on our foundation of success and deepening our commitment to excellence in China." This acquisition provides Solta Medical with an enhanced ability to address increasing market demand for aesthetics treatments through localized solutions and proven technologies. Building on a long-standing partnership, this acquisition reinforces Solta Medical's focus to gain direct insight into customer needs, preferences and service in the Chinese market. Jiny Kim, senior vice-president, Solta Medical, commented: "The Shibo group has been integral to the success of Thermage in China for more than a decade. Integrating their team into Solta Medical allows us to build on that trust and deliver even greater value-accelerating innovation by being closer to our customers, enhancing service and ensuring patients continue to receive high-quality treatments." Belinda Bao, vice-president, general manager, Solta China, added: "This step puts Solta Medical in a stronger position as a growth driver for Bausch Health. We are now able to move quicker in the Chinese market and focus on delivering quality results with trusted technologies like Thermage." This strategic acquisition demonstrates Bausch Health's continuing commitment to advancing global aesthetics. By delivering reliable and innovative solutions, the company aims to support both providers and the patients they serve in the rapidly evolving aesthetics market. About Bausch Health Companies Inc. Bausch Health is a global, diversified pharmaceutical company enriching lives through its relentless drive to deliver better health care outcomes. It develops, manufactures and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through its controlling interest in Bausch + Lomb Corp. Its ambition is to be a globally integrated health care company, trusted and valued by patients, HCPs, employees and investors. Its aesthetic business, Solta Medical, is a global leader in the aesthetics market, whose vision is to develop and support trusted aesthetic brands that provide value to its customers and patients. About Wuhan Shibo Zhenmei Technology Co. Ltd. Wuhan Shibo Zhenmei Technology is a private distributor of medical beauty products located in Wuhan Shi, Hubei, China. We seek Safe Harbor.